Cme (CME) Equity Income (2009 - 2026)

Cme (CME) has 18 years of Equity Income data on file, last reported at $102.4 million in Q1 2026.

• Equity Income for Q1 2026 came in at $102.4 million, up 16.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $385.9 million (up 9.66% YoY), and the FY2025 annual result was $371.7 million, up 5.93% from the prior year.
• Equity Income grew to $102.4 million in Q1 2026 per CME's latest filing, from $88.2 million in the prior quarter.
• Over five years, Equity Income peaked at $102.4 million in Q1 2026 and troughed at $64.0 million in Q4 2022.
• A 5-year average of $83.7 million and a median of $86.4 million in 2024 frame the typical range for Equity Income.
• The sharpest annual moves came in 2022 and 2023: Equity Income surged 56.73% in 2022, then fell 13.97% in 2023.
• A 5-year view of Equity Income shows it stood at $64.0 million in 2022, then increased by 4.38% to $66.8 million in 2023, then jumped by 36.53% to $91.2 million in 2024, then declined by 3.29% to $88.2 million in 2025, then gained by 16.1% to $102.4 million in 2026.
• Business Quant data shows CME's Equity Income at $102.4 million in Q1 2026, $88.2 million in Q4 2025, and $96.3 million in Q3 2025.